Basal-bolus therapy with insulin degludec improves long-term glycaemic control with less nocturnal hypoglycaemia compared with insulin

被引：0
|
作者：
Russell-Jones, D. L. [1 ,2 ]
Francisco, A. O. [3 ]
Pei, H. [4 ]
Heller, S. R. [5 ]
机构：
[1] Royal Surrey Cty Hosp, Guildford, Surrey, England
[2] Univ Surrey, Guildford GU2 5XH, Surrey, England
[3] Novo Nordisk AS, Soborg, Denmark
[4] Novo Nordisk Inc, Princeton, NJ USA
[5] Univ Sheffield, Sch Med & Biosci, Sheffield S10 2TN, S Yorkshire, England
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1045
引用
收藏
页码：S425 / S425
页数：1
相关论文
共 50 条
  • [1] Basal-bolus therapy with insulin degludec improves long-term glycaemic control with fewer nocturnal hypoglycaemic events compared with insulin glargine in people with type 2 diabetes
    Hollander, P. A.
    King, A. B.
    Francisco, A. O.
    Endahl, L.
    Garber, A.
    DIABETOLOGIA, 2011, 54 : S421 - S421
  • [2] Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy
    Hollander, P.
    King, A. B.
    Del Prato, S.
    Sreenan, S.
    Balci, M. K.
    Munoz-Torres, M.
    Rosenstock, J.
    Hansen, C. T.
    Niemeyer, M.
    Garber, A. J.
    DIABETES OBESITY & METABOLISM, 2015, 17 (02): : 202 - 206
  • [3] Insulin Degludec Improves Long-Term Glycemic Control with Less Nocturnal Hypoglycemia Compared with Insulin Glargine: 1-Year Results from a Randomized Basal-Bolus Trial in Type 1 Diabetes
    Heller, Simon
    Francisco, Ann Marie O.
    Pei, Huiling
    Russell-Jones, David
    DIABETES, 2011, 60 : A19 - A19
  • [4] Insulin Degludec Improves Long-Term Glycemic Control with Less Nocturnal Hypoglycemia Compared with Insulin Glargine: 1-Year Results from a Randomized Basal-Bolus Trial in People with Type 2 Diabetes
    Garber, Alan J.
    King, Allen B.
    Francisco, Ann Marie O.
    Endahl, Lars
    Hollander, Priscilla A.
    DIABETES, 2011, 60 : A20 - A20
  • [5] Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN® Basal-Bolus Type 1): 2-year results of a randomized clinical trial
    Bode, B. W.
    Buse, J. B.
    Fisher, M.
    Garg, S. K.
    Marre, M.
    Merker, L.
    Renard, E.
    Russell-Jones, D. L.
    Hansen, C. T.
    Rana, A.
    Heller, S. R.
    DIABETIC MEDICINE, 2013, 30 (11) : 1293 - 1297
  • [6] Basal-bolus therapy with insulin detemir/insulin aspart improves glycaemic control and reduces hypoglycaemia: data from the German cohort of the PREDICTIVE study
    Ackermann, R. W.
    Hansen, J. B.
    Nauck, M.
    DIABETOLOGIA, 2006, 49 : 595 - 596
  • [7] Glucotab-Based Basal-Bolus Insulin Therapy for Inpatient Glycemic Control Using Insulin Degludec
    Mader, Julia K.
    Baumann, Petra M.
    Aberer, Felix
    Hochfellner, Daniel A.
    Simic, Amra
    Bytyqi, Lirie
    Poettler, Tina
    Hoell, Bernhard
    Fahrleitner-Pammer, Astrid
    Pieber, Thomas
    Beck, Peter
    DIABETES, 2021, 70
  • [8] Basal-bolus Insulin Therapy through an electronic Decision Support System for stationary glycemic Control with Insulin degludec
    Hochfellner, Daniel Alexander
    Baumann, Petra Martina
    Aberer, Felix
    Simic, Amra
    Bytyqi, Lirie
    Poettler, Tina
    Holl, Bernhard
    Fahrleitner-Pammer, Astrid
    Pieber, Thomas Rudolf
    Beck, Peter
    Mader, Julia
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 6) : 209 - 209
  • [9] Interest Degludec insulin, a new ultra-long analogue insulin in basal-bolus in diabete Type 1: compared with insulin Glargine
    Charpentier, G.
    Fontaine, P.
    Meneghini, L.
    Home, P.
    Wendisch, U.
    Ratner, R.
    Endahl, L.
    Johansen, T.
    Lyby, K.
    Jendle, J.
    Roberts, A.
    Devries, J. H.
    Birkeland, K.
    Cariou, Bertrand
    DIABETES & METABOLISM, 2011, 37 : A35 - A35
  • [10] Intensive Insulin Therapy (Basal-Bolus)
    Chico, Ana
    Corcoy, Rosa
    AMERICAN JOURNAL OF THERAPEUTICS, 2022, 29 (01) : E64 - E73
12345